Girard-Globa A - Search Results

1

Postprandial reverse cholesterol transport in type 2 diabetic patients: effect of a lipid lowering treatment.

Autran D, Attia N, Dedecjus M, Durlach V, Girard-Globa A. Autran D, et al. Among authors: girard globa a. Atherosclerosis. 2000 Dec;153(2):453-60. doi: 10.1016/s0021-9150(00)00428-7. Atherosclerosis. 2000. PMID: 11164435

2

Modulation of low density lipoprotein subclasses by alimentary lipemia in control and normotriglyceridemic non-insulin-dependent diabetic subjects.

Attia N, Durlach V, Paul JL, Soni T, Betoulle D, Girard-Globa A. Attia N, et al. Atherosclerosis. 1995 Mar;113(2):197-209. doi: 10.1016/0021-9150(94)05447-q. Atherosclerosis. 1995. PMID: 7605359

3

Postprandial cholesteryl ester transfer and high density lipoprotein composition in normotriglyceridemic non-insulin-dependent diabetic patients.

Durlach V, Attia N, Zahouani A, Leutenegger M, Girard-Globa A. Durlach V, et al. Atherosclerosis. 1996 Feb;120(1-2):155-65. doi: 10.1016/0021-9150(95)05697-1. Atherosclerosis. 1996. PMID: 8645357

4

Postprandial concentrations and distribution of apo C-III in type 2 diabetic patients. Effect Of bezafibrate treatment.

Attia N, Durlach V, Cambilleau M, Roche D, Girard-Globa A. Attia N, et al. Among authors: girard globa a. Atherosclerosis. 2000 Apr;149(2):427-33. doi: 10.1016/s0021-9150(99)00337-8. Atherosclerosis. 2000. PMID: 10729394

5

Basal and postprandial serum-promoted cholesterol efflux in normolipidemic subjects: Importance of fat mass distribution.

Autran D, Guerci B, Paul JL, Moulin P, Vergés B, Durlach V, Girard-Globa A. Autran D, et al. Among authors: girard globa a. Metabolism. 2001 Nov;50(11):1330-5. doi: 10.1053/meta.2001.27206. Metabolism. 2001. PMID: 11699052 Clinical Trial.

6

Post-prandial metabolism of triglyceride-rich lipoproteins in non-insulin-dependent diabetic patients before and after bezafibrate treatment.

Attia N, Durlach V, Roche D, Paul JL, Soni T, Zahouani A, Landron F, Labrousse F, Leutenegger M, Girard-Globa A. Attia N, et al. Eur J Clin Invest. 1997 Jan;27(1):55-63. doi: 10.1046/j.1365-2362.1997.790630.x. Eur J Clin Invest. 1997. PMID: 9041378

7

Sex-dependent association of a genetic polymorphism of cholesteryl ester transfer protein with high-density lipoprotein cholesterol and macrovascular pathology in type II diabetic patients.

Durlach A, Clavel C, Girard-Globa A, Durlach V. Durlach A, et al. Among authors: girard globa a. J Clin Endocrinol Metab. 1999 Oct;84(10):3656-9. doi: 10.1210/jcem.84.10.6064. J Clin Endocrinol Metab. 1999. PMID: 10523010

8

Analysis of the postprandial lipid metabolism: use of a 3-point test.

Guerci B, Paul JL, Hadjadj S, Durlach V, Vergès B, Attia N, Girard-Globa A, Drouin P. Guerci B, et al. Among authors: girard globa a. Diabetes Metab. 2001 Sep;27(4 Pt 1):449-57. Diabetes Metab. 2001. PMID: 11547218

9

[Role of cholesteryl ester transfer protein activity and genetic polymorphism in ischemic heart disease in type 2 diabetic patients].

Chaaba R, Smaoui M, Hammami S, Attia N, Ben Hamda K, Masmoudi AS, Mahjoub S, Bouslama A, Ben Farhat M, Girard-Globa A, Hammami M. Chaaba R, et al. Among authors: girard globa a. Tunis Med. 2004 Mar;82(3):282-8. Tunis Med. 2004. PMID: 15382463 French.

10

Fatty acid composition of an oral load affects chylomicron size in human subjects.

Sakr SW, Attia N, Haourigui M, Paul JL, Soni T, Vacher D, Girard-Globa A. Sakr SW, et al. Br J Nutr. 1997 Jan;77(1):19-31. doi: 10.1017/s0007114500002853. Br J Nutr. 1997. PMID: 9059227 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

57 results

Search Page

Filters